Globus Medical, Inc. (GMED) Revenue Growth
Globus Medical, Inc. (GMED) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2017-12-31 | 12.76% |
| 2018-12-31 | 12.11% |
| 2019-12-31 | 10.15% |
| 2020-12-31 | 0.47% |
| 2021-12-31 | 21.43% |
| 2022-12-31 | 6.76% |
| 2023-12-31 | 53.34% |
| 2024-12-31 | 60.62% |
| 2025-12-31 | 16.65% |
How GMED compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BSX | Boston Scientific Corporation | 19.87% |
| CERS | Cerus Corporation | 16.13% |
| FLGT | Fulgent Genetics Inc. | 13.83% |
| CI | The Cigna Group | 11.24% |
| STE | STERIS plc (Ireland) | 8.73% |
These are five companies in the same sector as GMED with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Globus Medical, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("GMED", 2025, "")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GMED | $77.51 | +1.57% | 0.14M |
| 3 | ||||
| 4 | ||||
| 5 |